| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biological Products | 18 | 2024 | 66 | 6.460 |
Why?
|
| Molecular Structure | 37 | 2024 | 244 | 3.240 |
Why?
|
| Ascomycota | 8 | 2022 | 21 | 3.070 |
Why?
|
| Candida albicans | 6 | 2023 | 48 | 2.530 |
Why?
|
| Antineoplastic Agents, Phytogenic | 8 | 2020 | 54 | 2.430 |
Why?
|
| Antifungal Agents | 4 | 2023 | 67 | 2.270 |
Why?
|
| Fungi | 8 | 2024 | 57 | 2.110 |
Why?
|
| Penicillium | 4 | 2024 | 5 | 1.930 |
Why?
|
| Antimalarials | 6 | 2025 | 25 | 1.900 |
Why?
|
| Triple Negative Breast Neoplasms | 6 | 2020 | 36 | 1.810 |
Why?
|
| Peptides, Cyclic | 5 | 2016 | 30 | 1.740 |
Why?
|
| Aspergillus | 5 | 2015 | 9 | 1.700 |
Why?
|
| Diterpenes | 5 | 2019 | 19 | 1.700 |
Why?
|
| Mycoplasma genitalium | 2 | 2024 | 2 | 1.680 |
Why?
|
| Biofilms | 5 | 2023 | 122 | 1.620 |
Why?
|
| Antineoplastic Agents | 13 | 2024 | 681 | 1.580 |
Why?
|
| Peptaibols | 4 | 2022 | 7 | 1.470 |
Why?
|
| Plasmodium falciparum | 6 | 2025 | 19 | 1.390 |
Why?
|
| Drug Discovery | 3 | 2020 | 37 | 1.350 |
Why?
|
| Indole Alkaloids | 4 | 2015 | 9 | 1.300 |
Why?
|
| Drug Screening Assays, Antitumor | 15 | 2024 | 103 | 1.190 |
Why?
|
| Anti-Bacterial Agents | 10 | 2024 | 534 | 1.180 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 13 | 2017 | 55 | 1.160 |
Why?
|
| Cell Line, Tumor | 21 | 2022 | 1341 | 1.140 |
Why?
|
| Plant Extracts | 7 | 2020 | 62 | 1.120 |
Why?
|
| Humans | 56 | 2025 | 28585 | 1.080 |
Why?
|
| Glycosides | 4 | 2015 | 8 | 1.070 |
Why?
|
| Polyketides | 3 | 2014 | 6 | 1.000 |
Why?
|
| Plants, Medicinal | 3 | 2015 | 18 | 0.920 |
Why?
|
| Microbial Sensitivity Tests | 9 | 2024 | 148 | 0.890 |
Why?
|
| Anti-Infective Agents | 2 | 2023 | 78 | 0.870 |
Why?
|
| Animals | 33 | 2024 | 10583 | 0.850 |
Why?
|
| Pyrans | 2 | 2019 | 8 | 0.850 |
Why?
|
| Porifera | 6 | 2008 | 9 | 0.840 |
Why?
|
| Free Radical Scavengers | 2 | 2014 | 23 | 0.840 |
Why?
|
| Biphenyl Compounds | 2 | 2014 | 22 | 0.830 |
Why?
|
| Antiprotozoal Agents | 2 | 2024 | 7 | 0.830 |
Why?
|
| Mitosporic Fungi | 1 | 2023 | 2 | 0.820 |
Why?
|
| Cryptosporidiosis | 1 | 2023 | 3 | 0.820 |
Why?
|
| Cryptosporidium | 1 | 2023 | 3 | 0.820 |
Why?
|
| Fluconazole | 1 | 2023 | 12 | 0.810 |
Why?
|
| Mycoplasma Infections | 1 | 2023 | 2 | 0.800 |
Why?
|
| Lipoproteins | 2 | 2016 | 99 | 0.800 |
Why?
|
| Nitroimidazoles | 1 | 2023 | 6 | 0.800 |
Why?
|
| Iron | 1 | 2024 | 117 | 0.790 |
Why?
|
| Streptococcus mutans | 3 | 2012 | 39 | 0.760 |
Why?
|
| Metabolomics | 3 | 2024 | 87 | 0.720 |
Why?
|
| Triterpenes | 2 | 2015 | 9 | 0.700 |
Why?
|
| Trichoderma | 1 | 2021 | 1 | 0.700 |
Why?
|
| Hypocrea | 1 | 2021 | 1 | 0.700 |
Why?
|
| Malaria | 2 | 2024 | 18 | 0.700 |
Why?
|
| Macrolides | 2 | 2019 | 19 | 0.670 |
Why?
|
| Cardenolides | 1 | 2020 | 1 | 0.670 |
Why?
|
| Calotropis | 1 | 2020 | 1 | 0.670 |
Why?
|
| Cordyceps | 1 | 2020 | 1 | 0.670 |
Why?
|
| Histone Deacetylase Inhibitors | 4 | 2021 | 26 | 0.660 |
Why?
|
| Anacardiaceae | 1 | 2020 | 1 | 0.650 |
Why?
|
| Marine Toxins | 2 | 2010 | 6 | 0.650 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2020 | 34 | 0.650 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2020 | 32 | 0.650 |
Why?
|
| Aspergillus niger | 3 | 2015 | 10 | 0.640 |
Why?
|
| Nerve Tissue Proteins | 3 | 2011 | 154 | 0.630 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2019 | 10 | 0.630 |
Why?
|
| Mephitidae | 1 | 2019 | 1 | 0.620 |
Why?
|
| Sulfur Compounds | 1 | 2019 | 3 | 0.620 |
Why?
|
| Pseudomonas | 2 | 2016 | 13 | 0.620 |
Why?
|
| Odorants | 1 | 2019 | 10 | 0.620 |
Why?
|
| Trichomonas vaginalis | 1 | 2019 | 7 | 0.620 |
Why?
|
| Organic Chemicals | 1 | 2019 | 14 | 0.620 |
Why?
|
| Aflatoxin B1 | 1 | 2019 | 1 | 0.620 |
Why?
|
| Magnetic Resonance Spectroscopy | 10 | 2021 | 180 | 0.620 |
Why?
|
| Macrocyclic Compounds | 1 | 2019 | 7 | 0.610 |
Why?
|
| Protective Agents | 1 | 2019 | 17 | 0.610 |
Why?
|
| Carcinogens | 1 | 2019 | 39 | 0.610 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 38 | 0.600 |
Why?
|
| Hypocreales | 3 | 2025 | 3 | 0.600 |
Why?
|
| DNA | 1 | 2020 | 375 | 0.600 |
Why?
|
| Enzyme Inhibitors | 4 | 2020 | 251 | 0.600 |
Why?
|
| Nuclear Proteins | 3 | 2011 | 249 | 0.590 |
Why?
|
| Epigenesis, Genetic | 3 | 2009 | 148 | 0.590 |
Why?
|
| Hepatocytes | 1 | 2019 | 80 | 0.580 |
Why?
|
| Stress, Physiological | 1 | 2019 | 96 | 0.570 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 5 | 2020 | 72 | 0.560 |
Why?
|
| Animals, Wild | 2 | 2016 | 13 | 0.560 |
Why?
|
| Picrates | 2 | 2014 | 2 | 0.550 |
Why?
|
| Structure-Activity Relationship | 9 | 2025 | 209 | 0.550 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 253 | 0.540 |
Why?
|
| Chemistry, Organic | 1 | 2017 | 4 | 0.530 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2024 | 115 | 0.530 |
Why?
|
| Biochemistry | 1 | 2017 | 10 | 0.530 |
Why?
|
| Sesquiterpenes | 3 | 2020 | 22 | 0.520 |
Why?
|
| Serratia | 1 | 2016 | 3 | 0.520 |
Why?
|
| Huntington Disease | 3 | 2012 | 9 | 0.510 |
Why?
|
| Pyridones | 2 | 2024 | 36 | 0.510 |
Why?
|
| Cell Cycle | 4 | 2017 | 162 | 0.510 |
Why?
|
| Drug Resistance | 3 | 2024 | 42 | 0.500 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 4 | 2020 | 37 | 0.500 |
Why?
|
| Genome | 2 | 2014 | 56 | 0.500 |
Why?
|
| Toxins, Biological | 1 | 2016 | 7 | 0.490 |
Why?
|
| Liver | 1 | 2019 | 456 | 0.490 |
Why?
|
| Drug Resistance, Microbial | 1 | 2016 | 36 | 0.490 |
Why?
|
| Soil Microbiology | 5 | 2021 | 104 | 0.480 |
Why?
|
| Chromatography, High Pressure Liquid | 5 | 2020 | 131 | 0.470 |
Why?
|
| Multigene Family | 3 | 2010 | 51 | 0.470 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2016 | 327 | 0.470 |
Why?
|
| Microbiota | 1 | 2016 | 98 | 0.460 |
Why?
|
| Neurodegenerative Diseases | 2 | 2016 | 25 | 0.450 |
Why?
|
| Xylariales | 1 | 2014 | 1 | 0.450 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2014 | 7 | 0.450 |
Why?
|
| Alternaria | 1 | 2014 | 1 | 0.450 |
Why?
|
| Benzoates | 1 | 2014 | 30 | 0.440 |
Why?
|
| Benzopyrans | 2 | 2011 | 22 | 0.430 |
Why?
|
| Brevibacillus | 1 | 2014 | 2 | 0.430 |
Why?
|
| Receptors, Androgen | 3 | 2020 | 26 | 0.430 |
Why?
|
| Pyrones | 2 | 2023 | 6 | 0.430 |
Why?
|
| Fungal Proteins | 2 | 2017 | 82 | 0.420 |
Why?
|
| Piperazines | 1 | 2014 | 50 | 0.420 |
Why?
|
| Hydroxamic Acids | 2 | 2014 | 18 | 0.420 |
Why?
|
| Methionine | 1 | 2013 | 38 | 0.420 |
Why?
|
| Toxoplasma | 2 | 2024 | 33 | 0.420 |
Why?
|
| Spiro Compounds | 1 | 2013 | 5 | 0.410 |
Why?
|
| Tyrosine | 1 | 2013 | 92 | 0.410 |
Why?
|
| Metabolome | 2 | 2015 | 68 | 0.410 |
Why?
|
| Steroids | 3 | 2019 | 58 | 0.400 |
Why?
|
| Swine | 1 | 2014 | 238 | 0.400 |
Why?
|
| Small Molecule Libraries | 1 | 2013 | 19 | 0.390 |
Why?
|
| Amphotericin B | 1 | 2013 | 19 | 0.390 |
Why?
|
| Azacitidine | 2 | 2010 | 8 | 0.390 |
Why?
|
| Photorhabdus | 1 | 2012 | 2 | 0.390 |
Why?
|
| Gryllidae | 1 | 2012 | 3 | 0.390 |
Why?
|
| Cyclopentanes | 1 | 2012 | 17 | 0.390 |
Why?
|
| Stilbenes | 3 | 2012 | 90 | 0.380 |
Why?
|
| Molecular Conformation | 6 | 2014 | 67 | 0.370 |
Why?
|
| Morphogenesis | 1 | 2012 | 22 | 0.370 |
Why?
|
| Oligopeptides | 1 | 2012 | 97 | 0.370 |
Why?
|
| Mouth | 1 | 2012 | 31 | 0.360 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 2 | 2011 | 19 | 0.360 |
Why?
|
| Furans | 1 | 2011 | 5 | 0.360 |
Why?
|
| Pyrroles | 1 | 2011 | 36 | 0.350 |
Why?
|
| Carcinoma, Merkel Cell | 2 | 2021 | 13 | 0.350 |
Why?
|
| Anthozoa | 1 | 2011 | 3 | 0.350 |
Why?
|
| Chromatography, Liquid | 2 | 2022 | 79 | 0.350 |
Why?
|
| Lipoxygenase Inhibitors | 3 | 2005 | 16 | 0.340 |
Why?
|
| Proteostasis Deficiencies | 1 | 2010 | 5 | 0.340 |
Why?
|
| Artemisinins | 2 | 2024 | 2 | 0.340 |
Why?
|
| Protozoan Proteins | 2 | 2025 | 54 | 0.340 |
Why?
|
| Apoptosis | 1 | 2014 | 777 | 0.340 |
Why?
|
| Ketones | 1 | 2010 | 7 | 0.330 |
Why?
|
| Poisons | 1 | 2010 | 2 | 0.330 |
Why?
|
| Harmful Algal Bloom | 1 | 2010 | 7 | 0.330 |
Why?
|
| Heterocyclic Compounds | 1 | 2010 | 15 | 0.330 |
Why?
|
| Prunus domestica | 2 | 2022 | 2 | 0.330 |
Why?
|
| Chrysophyta | 1 | 2010 | 2 | 0.330 |
Why?
|
| Eukaryota | 1 | 2010 | 19 | 0.330 |
Why?
|
| Eutrophication | 1 | 2010 | 13 | 0.320 |
Why?
|
| Polyphenols | 2 | 2022 | 17 | 0.320 |
Why?
|
| Naphthalenes | 2 | 2017 | 17 | 0.320 |
Why?
|
| Fishes | 1 | 2010 | 32 | 0.320 |
Why?
|
| Water Pollutants, Chemical | 1 | 2010 | 55 | 0.320 |
Why?
|
| Mass Spectrometry | 4 | 2019 | 191 | 0.310 |
Why?
|
| Lantana | 1 | 2009 | 2 | 0.310 |
Why?
|
| Skin Neoplasms | 2 | 2021 | 147 | 0.310 |
Why?
|
| Tubulin Modulators | 3 | 2019 | 17 | 0.310 |
Why?
|
| Lignans | 1 | 2009 | 10 | 0.310 |
Why?
|
| Microtubules | 3 | 2019 | 90 | 0.310 |
Why?
|
| Mutation | 3 | 2010 | 864 | 0.310 |
Why?
|
| Biosynthetic Pathways | 1 | 2009 | 12 | 0.310 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2009 | 26 | 0.310 |
Why?
|
| Biotechnology | 1 | 2009 | 17 | 0.310 |
Why?
|
| Benzyl Compounds | 1 | 2008 | 2 | 0.300 |
Why?
|
| Aspergillus fumigatus | 2 | 2023 | 9 | 0.300 |
Why?
|
| Genetic Engineering | 1 | 2008 | 24 | 0.300 |
Why?
|
| Hydrogen Peroxide | 2 | 2024 | 145 | 0.290 |
Why?
|
| Cell Survival | 5 | 2016 | 416 | 0.290 |
Why?
|
| Crystallography, X-Ray | 4 | 2014 | 222 | 0.290 |
Why?
|
| Female | 11 | 2023 | 15472 | 0.290 |
Why?
|
| Antioxidants | 4 | 2004 | 224 | 0.280 |
Why?
|
| Tea | 1 | 2007 | 7 | 0.280 |
Why?
|
| alpha-Synuclein | 1 | 2007 | 5 | 0.280 |
Why?
|
| Models, Molecular | 4 | 2017 | 452 | 0.270 |
Why?
|
| Hemerocallis | 2 | 2004 | 2 | 0.270 |
Why?
|
| Anthraquinones | 2 | 2024 | 4 | 0.270 |
Why?
|
| Peptide Synthases | 3 | 2013 | 4 | 0.270 |
Why?
|
| Mice | 11 | 2022 | 4735 | 0.250 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 2 | 2016 | 11 | 0.250 |
Why?
|
| Hydrolysis | 2 | 2020 | 60 | 0.250 |
Why?
|
| Laccase | 1 | 2005 | 2 | 0.240 |
Why?
|
| Glucosides | 2 | 2009 | 8 | 0.230 |
Why?
|
| Diketopiperazines | 1 | 2024 | 1 | 0.220 |
Why?
|
| Adenosine Triphosphatases | 1 | 2025 | 50 | 0.220 |
Why?
|
| Melanoma | 3 | 2017 | 140 | 0.220 |
Why?
|
| Siderophores | 1 | 2024 | 5 | 0.220 |
Why?
|
| Neoplasms | 2 | 2004 | 857 | 0.220 |
Why?
|
| Plasmodium berghei | 1 | 2024 | 2 | 0.220 |
Why?
|
| Chromans | 1 | 2004 | 59 | 0.210 |
Why?
|
| Toxoplasmosis | 1 | 2024 | 11 | 0.210 |
Why?
|
| Ferric Compounds | 1 | 2024 | 43 | 0.210 |
Why?
|
| Stereoisomerism | 4 | 2009 | 45 | 0.210 |
Why?
|
| Anti-HIV Agents | 1 | 2004 | 20 | 0.210 |
Why?
|
| Fruit | 2 | 2020 | 40 | 0.210 |
Why?
|
| Chromosome Segregation | 1 | 2024 | 57 | 0.210 |
Why?
|
| Hawaii | 2 | 2014 | 12 | 0.210 |
Why?
|
| Candida | 3 | 2011 | 22 | 0.200 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2024 | 72 | 0.200 |
Why?
|
| Tinidazole | 1 | 2023 | 3 | 0.200 |
Why?
|
| Mitochondria | 2 | 2020 | 396 | 0.200 |
Why?
|
| Doxycycline | 1 | 2023 | 19 | 0.200 |
Why?
|
| Metronidazole | 1 | 2023 | 16 | 0.200 |
Why?
|
| Colonic Neoplasms | 2 | 2017 | 121 | 0.200 |
Why?
|
| Phylogeny | 2 | 2016 | 489 | 0.200 |
Why?
|
| Texas | 2 | 2021 | 138 | 0.200 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2023 | 44 | 0.190 |
Why?
|
| HeLa Cells | 3 | 2019 | 208 | 0.190 |
Why?
|
| Magnoliopsida | 1 | 2002 | 7 | 0.180 |
Why?
|
| HIV Infections | 1 | 2004 | 161 | 0.180 |
Why?
|
| Pennsylvania | 1 | 2021 | 10 | 0.170 |
Why?
|
| Biodiversity | 1 | 2022 | 114 | 0.170 |
Why?
|
| Huntingtin Protein | 3 | 2011 | 3 | 0.170 |
Why?
|
| Hep G2 Cells | 1 | 2021 | 31 | 0.170 |
Why?
|
| Ultrafiltration | 1 | 2020 | 3 | 0.170 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 36 | 0.170 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2020 | 10 | 0.170 |
Why?
|
| Daptomycin | 1 | 2020 | 6 | 0.170 |
Why?
|
| Pigments, Biological | 2 | 2010 | 8 | 0.170 |
Why?
|
| United States | 2 | 2017 | 2201 | 0.160 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 49 | 0.160 |
Why?
|
| Rosales | 1 | 2000 | 1 | 0.160 |
Why?
|
| Botrytis | 1 | 2000 | 1 | 0.160 |
Why?
|
| Phytochemicals | 1 | 2020 | 9 | 0.160 |
Why?
|
| Polyketide Synthases | 2 | 2010 | 6 | 0.160 |
Why?
|
| Vietnam | 1 | 2020 | 44 | 0.160 |
Why?
|
| Drug Synergism | 3 | 2016 | 104 | 0.160 |
Why?
|
| Pyrrolidinones | 1 | 2019 | 3 | 0.160 |
Why?
|
| Trichomonas Vaginitis | 1 | 2019 | 2 | 0.160 |
Why?
|
| Quinones | 1 | 2019 | 23 | 0.160 |
Why?
|
| Oxygen Consumption | 1 | 2020 | 181 | 0.150 |
Why?
|
| Neoplastic Stem Cells | 1 | 2020 | 141 | 0.150 |
Why?
|
| Rhizopus | 1 | 2019 | 3 | 0.150 |
Why?
|
| Calcium | 1 | 2020 | 243 | 0.150 |
Why?
|
| Burkholderia | 1 | 2019 | 6 | 0.150 |
Why?
|
| Spectrophotometry, Ultraviolet | 2 | 2010 | 54 | 0.150 |
Why?
|
| Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein | 1 | 2019 | 1 | 0.150 |
Why?
|
| Sarcoma, Ewing | 1 | 2019 | 15 | 0.150 |
Why?
|
| Symbiosis | 1 | 2019 | 36 | 0.150 |
Why?
|
| Brain | 2 | 2016 | 753 | 0.140 |
Why?
|
| Zebrafish | 1 | 2019 | 96 | 0.140 |
Why?
|
| Fibroblasts | 1 | 2019 | 160 | 0.140 |
Why?
|
| Dioscoreaceae | 1 | 2018 | 1 | 0.140 |
Why?
|
| Cell Proliferation | 5 | 2019 | 817 | 0.140 |
Why?
|
| Oxazoles | 1 | 2017 | 5 | 0.140 |
Why?
|
| Genome, Fungal | 1 | 2017 | 7 | 0.140 |
Why?
|
| Proline | 1 | 2017 | 11 | 0.140 |
Why?
|
| Bacillus cereus | 1 | 1998 | 59 | 0.140 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 524 | 0.140 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2017 | 4 | 0.140 |
Why?
|
| Osteoblasts | 1 | 2017 | 39 | 0.140 |
Why?
|
| Imidazoles | 1 | 2017 | 63 | 0.140 |
Why?
|
| Breast Neoplasms | 2 | 2020 | 472 | 0.130 |
Why?
|
| Cell Line | 1 | 2019 | 698 | 0.130 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2017 | 30 | 0.130 |
Why?
|
| Pancreatic Neoplasms | 2 | 2014 | 548 | 0.130 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 410 | 0.130 |
Why?
|
| History, 21st Century | 1 | 2017 | 49 | 0.130 |
Why?
|
| Protein Conformation | 1 | 2017 | 257 | 0.130 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2010 | 177 | 0.130 |
Why?
|
| History, 20th Century | 1 | 2017 | 84 | 0.130 |
Why?
|
| Vertebrates | 1 | 2016 | 18 | 0.130 |
Why?
|
| Signal Transduction | 5 | 2017 | 1455 | 0.130 |
Why?
|
| Phenyl Ethers | 2 | 2014 | 3 | 0.130 |
Why?
|
| Capsicum | 1 | 1996 | 2 | 0.130 |
Why?
|
| Indians, Central American | 1 | 1996 | 4 | 0.130 |
Why?
|
| Phenylthiohydantoin | 1 | 2016 | 3 | 0.130 |
Why?
|
| Medicine, Traditional | 1 | 1996 | 10 | 0.130 |
Why?
|
| Mammals | 1 | 2016 | 48 | 0.130 |
Why?
|
| Rotenone | 1 | 2016 | 5 | 0.130 |
Why?
|
| Ampicillin | 1 | 2016 | 14 | 0.120 |
Why?
|
| Sesquiterpenes, Germacrane | 1 | 2016 | 1 | 0.120 |
Why?
|
| Chalcones | 1 | 2016 | 1 | 0.120 |
Why?
|
| Polyethyleneimine | 1 | 2016 | 18 | 0.120 |
Why?
|
| Amino Acids | 2 | 2022 | 85 | 0.120 |
Why?
|
| Transplantation, Heterologous | 2 | 2013 | 60 | 0.120 |
Why?
|
| Umbelliferones | 1 | 2015 | 2 | 0.120 |
Why?
|
| Life Cycle Stages | 1 | 2015 | 6 | 0.120 |
Why?
|
| Quinine | 1 | 2015 | 23 | 0.120 |
Why?
|
| Malaria, Falciparum | 1 | 2015 | 7 | 0.120 |
Why?
|
| Sirolimus | 1 | 2016 | 76 | 0.120 |
Why?
|
| Deuterium | 1 | 2015 | 50 | 0.120 |
Why?
|
| Isotope Labeling | 1 | 2015 | 31 | 0.120 |
Why?
|
| Genetic Variation | 1 | 2016 | 245 | 0.120 |
Why?
|
| Soil | 2 | 2020 | 87 | 0.120 |
Why?
|
| Klebsiella pneumoniae | 1 | 2014 | 29 | 0.110 |
Why?
|
| G2 Phase | 1 | 2014 | 15 | 0.110 |
Why?
|
| Solidago | 1 | 2014 | 1 | 0.110 |
Why?
|
| Disease Models, Animal | 3 | 2016 | 1494 | 0.110 |
Why?
|
| Phytotherapy | 2 | 2009 | 22 | 0.110 |
Why?
|
| Shikimic Acid | 1 | 2013 | 1 | 0.110 |
Why?
|
| Genes, Bacterial | 1 | 2014 | 109 | 0.100 |
Why?
|
| Coculture Techniques | 1 | 2013 | 55 | 0.100 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 57 | 0.100 |
Why?
|
| Oxygen | 2 | 2016 | 234 | 0.100 |
Why?
|
| Dimerization | 2 | 2005 | 76 | 0.100 |
Why?
|
| Models, Chemical | 2 | 2010 | 90 | 0.100 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 282 | 0.100 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 113 | 0.100 |
Why?
|
| Stroke | 1 | 2016 | 256 | 0.100 |
Why?
|
| Benzofurans | 1 | 2012 | 6 | 0.100 |
Why?
|
| Child | 1 | 2019 | 2271 | 0.100 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2012 | 80 | 0.090 |
Why?
|
| Hyphae | 1 | 2012 | 8 | 0.090 |
Why?
|
| Sirtuin 3 | 1 | 2012 | 18 | 0.090 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2012 | 34 | 0.090 |
Why?
|
| Sargassum | 1 | 2012 | 1 | 0.090 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 43 | 0.090 |
Why?
|
| Fermentation | 1 | 2012 | 51 | 0.090 |
Why?
|
| Candidiasis | 1 | 2012 | 25 | 0.090 |
Why?
|
| Aspergillus flavus | 1 | 2011 | 2 | 0.090 |
Why?
|
| Cell Adhesion | 1 | 2012 | 139 | 0.090 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2003 | 25 | 0.090 |
Why?
|
| Sirtuin 1 | 1 | 2011 | 41 | 0.090 |
Why?
|
| Metagenome | 1 | 2012 | 52 | 0.090 |
Why?
|
| Recombinant Proteins | 2 | 2015 | 415 | 0.090 |
Why?
|
| Male | 3 | 2023 | 13772 | 0.090 |
Why?
|
| Oklahoma | 1 | 2014 | 1038 | 0.090 |
Why?
|
| Staphylococcus epidermidis | 1 | 2010 | 6 | 0.080 |
Why?
|
| Terpenes | 1 | 2010 | 8 | 0.080 |
Why?
|
| Chemical Phenomena | 1 | 2010 | 22 | 0.080 |
Why?
|
| DNA Modification Methylases | 1 | 2010 | 13 | 0.080 |
Why?
|
| Catechin | 2 | 2007 | 13 | 0.080 |
Why?
|
| Alkalies | 1 | 2010 | 6 | 0.080 |
Why?
|
| Esterases | 1 | 2010 | 16 | 0.080 |
Why?
|
| Biological Assay | 1 | 2010 | 34 | 0.080 |
Why?
|
| Fourier Analysis | 1 | 2010 | 31 | 0.080 |
Why?
|
| Carbohydrate Metabolism | 1 | 2010 | 30 | 0.080 |
Why?
|
| Base Sequence | 1 | 2011 | 588 | 0.080 |
Why?
|
| Principal Component Analysis | 1 | 2010 | 51 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 145 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2010 | 269 | 0.080 |
Why?
|
| Caffeic Acids | 1 | 2009 | 3 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2009 | 133 | 0.080 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2010 | 68 | 0.080 |
Why?
|
| Expressed Sequence Tags | 1 | 2009 | 8 | 0.080 |
Why?
|
| Biotransformation | 2 | 2000 | 9 | 0.080 |
Why?
|
| Gene Library | 1 | 2009 | 45 | 0.080 |
Why?
|
| Complex Mixtures | 2 | 2022 | 12 | 0.080 |
Why?
|
| Thiazolidines | 1 | 2008 | 6 | 0.080 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2008 | 52 | 0.070 |
Why?
|
| Fatty Acids | 1 | 2010 | 209 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 328 | 0.070 |
Why?
|
| Chromatography, Thin Layer | 1 | 2008 | 18 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2009 | 247 | 0.070 |
Why?
|
| Vancomycin | 2 | 2020 | 58 | 0.070 |
Why?
|
| RNA, Ribosomal | 1 | 2008 | 51 | 0.070 |
Why?
|
| Arachidonate 15-Lipoxygenase | 2 | 2004 | 2 | 0.070 |
Why?
|
| Phenotype | 1 | 2010 | 682 | 0.070 |
Why?
|
| Taxoids | 1 | 2007 | 37 | 0.070 |
Why?
|
| Tubulin | 2 | 2017 | 32 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 155 | 0.060 |
Why?
|
| Staphylococcus aureus | 2 | 2020 | 121 | 0.060 |
Why?
|
| Catalysis | 1 | 2005 | 133 | 0.060 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2016 | 275 | 0.060 |
Why?
|
| Molecular Docking Simulation | 1 | 2025 | 52 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2022 | 1602 | 0.060 |
Why?
|
| Bacterial Proteins | 2 | 2024 | 491 | 0.060 |
Why?
|
| Hydrocarbons, Brominated | 1 | 2004 | 2 | 0.060 |
Why?
|
| Coumarins | 1 | 2004 | 5 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2004 | 267 | 0.050 |
Why?
|
| Lipid Peroxidation | 1 | 2004 | 48 | 0.050 |
Why?
|
| Vitamin E | 1 | 2004 | 11 | 0.050 |
Why?
|
| Soybeans | 1 | 2004 | 36 | 0.050 |
Why?
|
| Ascorbic Acid | 1 | 2004 | 24 | 0.050 |
Why?
|
| Pentacyclic Triterpenes | 1 | 2004 | 3 | 0.050 |
Why?
|
| Environmental Pollutants | 1 | 2004 | 35 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2004 | 50 | 0.050 |
Why?
|
| Cell Division | 1 | 2004 | 154 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2004 | 366 | 0.050 |
Why?
|
| Malus | 1 | 2003 | 4 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2004 | 78 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2024 | 265 | 0.050 |
Why?
|
| Prebiotics | 1 | 2022 | 3 | 0.050 |
Why?
|
| Estrogens | 1 | 2022 | 56 | 0.050 |
Why?
|
| Chemical Fractionation | 2 | 2016 | 9 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 633 | 0.040 |
Why?
|
| Bone Density | 1 | 2022 | 101 | 0.040 |
Why?
|
| Escherichia coli | 2 | 2015 | 338 | 0.040 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2020 | 3 | 0.040 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2020 | 10 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2002 | 135 | 0.040 |
Why?
|
| PPAR gamma | 1 | 2020 | 29 | 0.040 |
Why?
|
| Vero Cells | 1 | 2000 | 12 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 695 | 0.040 |
Why?
|
| HIV-1 | 1 | 2000 | 58 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 198 | 0.040 |
Why?
|
| Rats | 2 | 2012 | 1587 | 0.040 |
Why?
|
| Rutaceae | 1 | 2017 | 1 | 0.030 |
Why?
|
| Smad6 Protein | 1 | 2017 | 1 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2017 | 16 | 0.030 |
Why?
|
| Calcification, Physiologic | 1 | 2017 | 4 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2017 | 31 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1998 | 191 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2017 | 81 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2018 | 332 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 95 | 0.030 |
Why?
|
| Oleanolic Acid | 1 | 2016 | 1 | 0.030 |
Why?
|
| Nerium | 1 | 2016 | 1 | 0.030 |
Why?
|
| Receptors, Progesterone | 1 | 2016 | 17 | 0.030 |
Why?
|
| Penicillin-Binding Proteins | 1 | 2016 | 9 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 247 | 0.030 |
Why?
|
| Nitriles | 1 | 2016 | 33 | 0.030 |
Why?
|
| Receptor, ErbB-2 | 1 | 2016 | 33 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2016 | 56 | 0.030 |
Why?
|
| Streptococcus pyogenes | 1 | 1996 | 30 | 0.030 |
Why?
|
| Teichoic Acids | 1 | 2016 | 18 | 0.030 |
Why?
|
| Benzamides | 1 | 2016 | 34 | 0.030 |
Why?
|
| Bacillus | 1 | 1996 | 25 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 2016 | 52 | 0.030 |
Why?
|
| Species Specificity | 1 | 1996 | 193 | 0.030 |
Why?
|
| Models, Biological | 1 | 1998 | 468 | 0.030 |
Why?
|
| Clostridium | 1 | 1996 | 61 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 2015 | 25 | 0.030 |
Why?
|
| Cell Wall | 1 | 2016 | 67 | 0.030 |
Why?
|
| Insect Vectors | 1 | 2015 | 12 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 82 | 0.030 |
Why?
|
| Anopheles | 1 | 2015 | 12 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2016 | 138 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 135 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2015 | 208 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2015 | 88 | 0.030 |
Why?
|
| DNA Damage | 1 | 2016 | 151 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2017 | 1009 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 554 | 0.030 |
Why?
|
| Missouri | 1 | 2014 | 9 | 0.030 |
Why?
|
| Endangered Species | 1 | 2014 | 6 | 0.030 |
Why?
|
| Glucose | 1 | 2016 | 208 | 0.030 |
Why?
|
| Algorithms | 1 | 2017 | 430 | 0.030 |
Why?
|
| Gene Expression | 1 | 2015 | 417 | 0.030 |
Why?
|
| Protein Binding | 1 | 2015 | 664 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 465 | 0.030 |
Why?
|
| Artemia | 1 | 2012 | 1 | 0.020 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2011 | 4 | 0.020 |
Why?
|
| Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2011 | 3 | 0.020 |
Why?
|
| Receptor, trkB | 1 | 2011 | 8 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 35 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2011 | 22 | 0.020 |
Why?
|
| Gene Order | 1 | 2010 | 10 | 0.020 |
Why?
|
| Aerobiosis | 1 | 2010 | 14 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2012 | 206 | 0.020 |
Why?
|
| Genomic Islands | 1 | 2010 | 11 | 0.020 |
Why?
|
| Oxidants | 1 | 2010 | 31 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 166 | 0.020 |
Why?
|
| Neurons | 1 | 2011 | 291 | 0.020 |
Why?
|
| Heterocyclic Compounds, 2-Ring | 1 | 2008 | 3 | 0.020 |
Why?
|
| Lactones | 1 | 2008 | 7 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2008 | 231 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2007 | 60 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2007 | 90 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 611 | 0.020 |
Why?
|
| Dioxins | 1 | 2004 | 1 | 0.010 |
Why?
|
| Polybrominated Biphenyls | 1 | 2004 | 1 | 0.010 |
Why?
|
| Arachidonate 12-Lipoxygenase | 1 | 2004 | 2 | 0.010 |
Why?
|
| Flame Retardants | 1 | 2004 | 2 | 0.010 |
Why?
|
| Reticulocytes | 1 | 2004 | 41 | 0.010 |
Why?
|
| Phenols | 1 | 2004 | 22 | 0.010 |
Why?
|
| Plant Leaves | 1 | 2004 | 57 | 0.010 |
Why?
|
| Amygdalin | 1 | 2003 | 1 | 0.010 |
Why?
|
| Cyclooxygenase 1 | 1 | 2003 | 9 | 0.010 |
Why?
|
| Liposomes | 1 | 2004 | 145 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 24 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2003 | 86 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2003 | 68 | 0.010 |
Why?
|
| Blood Platelets | 1 | 2004 | 206 | 0.010 |
Why?
|